France is grappling with a sudden surge in chikungunya cases, just as the U.S. pauses its vaccine approval-raising urgent concerns about controlling the outbreak and securing vaccine availability amid rising infections, RFI reports
France is grappling with a sudden surge in chikungunya cases, just as the U.S. pauses its vaccine approval-raising urgent concerns about controlling the outbreak and securing vaccine availability amid rising infections, RFI reports
